These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 34498329)

  • 1. Automated speech analysis in early untreated Parkinson's disease: Relation to gender and dopaminergic transporter imaging.
    Rusz J; Tykalová T; Novotný M; Zogala D; Růžička E; Dušek P
    Eur J Neurol; 2022 Jan; 29(1):81-90. PubMed ID: 34498329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dopaminergic replacement therapy on motor speech disorders in Parkinson's disease: longitudinal follow-up study on previously untreated patients.
    Rusz J; Tykalová T; Klempíř J; Čmejla R; Růžička E
    J Neural Transm (Vienna); 2016 Apr; 123(4):379-87. PubMed ID: 26843071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct patterns of speech disorder in early-onset and late-onset de-novo Parkinson's disease.
    Rusz J; Tykalová T; Novotný M; Růžička E; Dušek P
    NPJ Parkinsons Dis; 2021 Nov; 7(1):98. PubMed ID: 34764299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining Speech Subtypes in De Novo Parkinson Disease: Response to Long-term Levodopa Therapy.
    Rusz J; Tykalova T; Novotny M; Zogala D; Sonka K; Ruzicka E; Dusek P
    Neurology; 2021 Nov; 97(21):e2124-e2135. PubMed ID: 34607922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Susceptibility Associates With Dopaminergic Deficits and Cognition in Parkinson's Disease.
    Uchida Y; Kan H; Sakurai K; Inui S; Kobayashi S; Akagawa Y; Shibuya K; Ueki Y; Matsukawa N
    Mov Disord; 2020 Aug; 35(8):1396-1405. PubMed ID: 32369660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative analysis of speech impairment and upper limb motor dysfunction in Parkinson's disease.
    Rusz J; Tykalová T; Krupička R; Zárubová K; Novotný M; Jech R; Szabó Z; Růžička E
    J Neural Transm (Vienna); 2017 Apr; 124(4):463-470. PubMed ID: 27933492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speech disorder and vocal tremor in postural instability/gait difficulty and tremor dominant subtypes of Parkinson's disease.
    Tykalová T; Rusz J; Švihlík J; Bancone S; Spezia A; Pellecchia MT
    J Neural Transm (Vienna); 2020 Sep; 127(9):1295-1304. PubMed ID: 32651925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Automated video-based assessment of facial bradykinesia in de-novo Parkinson's disease.
    Novotny M; Tykalova T; Ruzickova H; Ruzicka E; Dusek P; Rusz J
    NPJ Digit Med; 2022 Jul; 5(1):98. PubMed ID: 35851859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease.
    Rusz J; Cmejla R; Ruzickova H; Ruzicka E
    J Acoust Soc Am; 2011 Jan; 129(1):350-67. PubMed ID: 21303016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease.
    Koros C; Simitsi A; Prentakis A; Beratis I; Papadimitriou D; Kontaxopoulou D; Fragkiadaki S; Papagiannakis N; Seibyl J; Marek K; Papageorgiou SG; Trapali XG; Stamelou M; Stefanis L
    Mov Disord; 2018 Nov; 33(11):1734-1739. PubMed ID: 30288781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Speech difficulties in early de novo patients with Parkinson's disease.
    Polychronis S; Niccolini F; Pagano G; Yousaf T; Politis M
    Parkinsonism Relat Disord; 2019 Jul; 64():256-261. PubMed ID: 31078401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term effect of dopaminergic medication on speech in early-stage Parkinson's disease.
    Tykalova T; Novotny M; Ruzicka E; Dusek P; Rusz J
    NPJ Parkinsons Dis; 2022 Mar; 8(1):22. PubMed ID: 35256614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nigro-caudate dopaminergic deafferentation: a marker of REM sleep behavior disorder?
    Arnaldi D; De Carli F; Picco A; Ferrara M; Accardo J; Bossert I; Famà F; Girtler N; Morbelli S; Sambuceti G; Nobili F
    Neurobiol Aging; 2015 Dec; 36(12):3300-3305. PubMed ID: 26410306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.
    Rusz J; Cmejla R; Růžičková H; Klempíř J; Majerová V; Picmausová J; Roth J; Růžička E
    J Neural Transm (Vienna); 2013 Feb; 120(2):319-29. PubMed ID: 22772465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal Dopamine Denervation Impairs Gait Automaticity in Drug-Naïve Parkinson's Disease Patients.
    Hirata K; Hattori T; Kina S; Chen Q; Ohara M; Yokota T
    Mov Disord; 2020 Jun; 35(6):1037-1045. PubMed ID: 32163636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Speech disorders in Parkinson's disease: early diagnostics and effects of medication and brain stimulation.
    Brabenec L; Mekyska J; Galaz Z; Rektorova I
    J Neural Transm (Vienna); 2017 Mar; 124(3):303-334. PubMed ID: 28101650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levodopa may modulate specific speech impairment in Parkinson's disease: an fMRI study.
    Mračková M; Mareček R; Mekyska J; Košťálová M; Rektorová I
    J Neural Transm (Vienna); 2024 Feb; 131(2):181-187. PubMed ID: 37943390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aspects of speech rate and regularity in Parkinson's disease.
    Skodda S
    J Neurol Sci; 2011 Nov; 310(1-2):231-6. PubMed ID: 21849174
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic Correlates of Orthostatic Hypotension in de novo Parkinson's Disease.
    Umehara T; Oka H; Nakahara A; Shiraishi T; Sato T; Matsuno H; Komatsu T; Omoto S; Murakami H; Iguchi Y
    J Parkinsons Dis; 2021; 11(2):665-673. PubMed ID: 33361609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task.
    Rusz J; Cmejla R; Tykalova T; Ruzickova H; Klempir J; Majerova V; Picmausova J; Roth J; Ruzicka E
    J Acoust Soc Am; 2013 Sep; 134(3):2171-81. PubMed ID: 23967947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.